3D-printed 'spanlastics' could change how cancer drugs reach tumors

University of Mississippi research offers hope that cancer drug therapies packaged in 3D-printed carriers could deliver medication directly to tumors while reducing many of the side effects that cancer patients endure. In a study published in Pharmaceutical Research, the Ole Miss team demonstrated that 3D-printed spanlastics—a tiny carrier filled with cancer-fighting drugs—could be implanted directly at the site of a tumor and kill those cells.